Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease

American Journal of Gastroenterology

Volumn 95, Issue 11, 2000, Pages 3189-3194

  Kugathasan, Subra ^a,b,c   Werlin, Steven L ^a,b,c   Martinez, Alfonzo ^a,b,c   Rivera, Maria T ^a,b,c   Heikenen, Janice B ^a,b,c   Binion, David G ^a,b,c  

^a CHILDREN S HOSPITAL OF WISCONSIN   (United States)

^b MARSHFIELD CLINIC   (United States)

^c FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; PREDNISONE; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INFLAMMATION; INFUSION; MALE; PRIORITY JOURNAL; REMISSION; SCORING SYSTEM;

ANTIBODIES, MONOCLONAL; CHILD; CROHN DISEASE; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033761188     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)02056-6     Document Type: Article

References (14)

1. Inflammatory bowel disease: Etiology and pathogenesis
2. Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease
3. Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease
4. 6-Mercaptopurine (6MP) + prednisone therapy for newly diagnosed pediatric Crohn's disease (CD): A prospective, randomized multicenter placebo-controlled clinical trial
5. Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease
6. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group
7. Infliximab for the treatment of fistulas in patients with Crohn's disease
8. Treatment of pediatric Crohn's disease (CD) with anti-tumor necrosis factor alpha chimeric monoclonal antibody (infliximab)
9. A multicenter study of infliximab (anti-TNF-alpha antibody) in the treatment of children with active Crohn's disease
10. Development and validation of a pediatric Crohn's disease activity index
11. Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease
12. Clonal T cell cytokine secretion is modulated in mucosa of children with recent onset but not chronic inflammatory bowel disease
13. Distinct mucosal T cell responses to IL-12 in early and late stages of inflammatory bowel diseases
14. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the USA-USSR double-blind, placebo-controlled trial